关注
Eun Hye Kim
Eun Hye Kim
Kist, Korea university
在 kist.re.kr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exosomes: cell-derived nanoplatforms for the delivery of cancer therapeutics
H Kim, EH Kim, G Kwak, SG Chi, SH Kim, Y Yang
International journal of molecular sciences 22 (1), 14, 2020
1102020
Harnessing the natural healing power of colostrum: bovine milk‐derived extracellular vesicles from colostrum facilitating the transition from inflammation to tissue …
H Kim, DE Kim, G Han, NR Lim, EH Kim, Y Jang, H Cho, H Jang, KH Kim, ...
Advanced Healthcare Materials 11 (6), 2102027, 2022
422022
Potential of colostrum-derived exosomes for promoting hair regeneration through the transition from telogen to anagen phase
H Kim, Y Jang, EH Kim, H Jang, H Cho, G Han, HK Song, SH Kim, Y Yang
Frontiers in Cell and Developmental Biology 10, 815205, 2022
392022
Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress
G Han, H Cho, H Kim, Y Jang, H Jang, ES Kim, EH Kim, KY Hwang, K Kim, ...
Biomaterials Science 10 (8), 2076-2087, 2022
382022
Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer
H Kim, HJ Park, HW Chang, JH Back, SJ Lee, YE Park, EH Kim, Y Hong, ...
Bioactive Materials 25, 527-540, 2023
282023
The potential of cell-penetrating peptides for mRNA delivery to cancer cells
Y Kim, H Kim, EH Kim, H Jang, Y Jang, SG Chi, Y Yang, SH Kim
Pharmaceutics 14 (6), 1271, 2022
282022
A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA
G Kwak, H Kim, J Park, EH Kim, H Jang, G Han, SY Wang, Y Yang, ...
ACS nano 15 (7), 11369-11384, 2021
252021
Nanoparticles targeting innate immune cells in tumor microenvironment
H Jang, EH Kim, SG Chi, SH Kim, Y Yang
International journal of molecular sciences 22 (18), 10009, 2021
222021
mRNA: A promising platform for cancer immunotherapy
B Kong, Y Kim, EH Kim, JS Suk, Y Yang
Advanced Drug Delivery Reviews, 114993, 2023
192023
Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery
H Jang, H Kim, EH Kim, G Han, Y Jang, Y Kim, JW Lee, SC Shin, EEK Kim, ...
Biomaterials Research 27 (1), 124, 2023
112023
PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs
EH Kim, J Lee, G Kwak, H Jang, H Kim, H Cho, Y Jang, J Choi, SG Chi, ...
Journal of Controlled Release 345, 62-74, 2022
112022
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
Y Kim, J Choi, EH Kim, W Park, H Jang, Y Jang, SG Chi, DH Kweon, ...
Advanced Science, 2309917, 2024
102024
Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors
JW Lee, J Choi, EH Kim, J Choi, SH Kim, Y Yang
ACS omega 8 (39), 36435-36448, 2023
32023
Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death
EH Kim, J Choi, H Jang, Y Kim, JW Lee, Y Ryu, J Choi, Y Choi, SG Chi, ...
Theranostics 14 (10), 3777, 2024
12024
Targeting miR-21 to Overcome P-glycoprotein Drug Efflux in Doxorubicin-Resistant 4T1 Breast Cancer
EH Kim, Y Ryu, J Choi, D Park, JW Lee, SG Chi, SH Kim, Y Yang
Biomaterials Research 28, 0095, 2024
2024
Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy
JW Lee, HY Yoon, YJ Ko, EH Kim, S Song, S Hue, N Gupta, D Malin, ...
ACS nano 18 (33), 22298-22315, 2024
2024
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs
H Jang, J Choi, D Park, G Han, EH Kim, K Kim, SH Kim, MK Shim, Y Yang
Theranostics 14 (14), 5413, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–17